This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The FDA expressed concern, specifically, about in-vitro studies, which are run to test biological processes. The agency identified “significant” problems with data integrity and the way studies were conducted by Raptim Research, which had been hired by the drugmakers to test their medicines.
Unlike traditional consumer brands, pharmaceuticalcompanies face unique challenges on social media, including strict regulations, compliance concerns, and the need for factual accuracy. For pharmaceuticalcompanies, this can provide insights into public perception of drug launches, patient experiences, and industry discussions.
pharmaceuticalcompanies didn’t license any new drugs from China. Five years ago, U.S. By 2024, one-third of their new compounds were coming from Chinese biotechnology firms. Why are U.S. drugmakers sending their business to China?
Common brand-name drugs that contain this ingredient include Ozempic , Wegovy , and Rybelsus all manufactured by Novo Nordisk, a Danish pharmaceuticalcompany. Food and Drug Administration (FDA). Their purpose is to meet an individual patients specific needs when an FDA-approved drug doesnt.
Adhering to guidelines from the FDA and other governing bodies ensures that campaigns remain effective without crossing ethical boundaries. Q4: How can pharma companies stay compliant with marketing regulations? By adhering to FDA guidelines, involving legal teams in campaign planning, and regularly auditing content for compliance.
Use relatable metaphors: Think of content as a bridge connecting pharma companies with patients and HCPs. Navigating Regulatory Compliance Pharmaceutical advertising operates under strict regulations. Always adhere to FDA guidelines and include clear disclaimers in campaigns. Non-compliance can cost dearly.
This is especially relevant for prescription drug ads, which must comply with FDA guidelines on fair balance and risk disclosure. Smaller pharmaceuticalcompanies often find it difficult to compete with the budgets of major players. Second, cost-per-click rates have soared in competitive therapeutic areas.
In the digital-first era, social media marketing strategies are reshaping how pharmaceuticalcompanies engage with healthcare professionals, patients, and caregivers. However, every claim must be backed by science and formatted according to FDA and FTC guidelines. Can pharma companies use paid social ads?
On the patient side, pharmaceuticalcompanies have launched ambassador and mentorship programs. Instead of investing heavily in broad messaging, pharma companies focus on nurturing advocates who organically amplify their message. Every message, endorsement, or testimonial must meet FDA, FTC, and local privacy regulations.
Author(s): Nicholas Jacobus Key Takeaways Vizz, an aceclidine-based eye drop, is FDA-approved for presbyopia, enhancing near vision without myopic shifts. SHOW MORE LENZ Therapeutics celebrates FDA approval of Vizz, the first aceclidine eye drop for presbyopia. I want to thank each of them for their role in getting Vizz FDA approved.”
Niche healthcare advertising sponsorships are partnerships where pharmaceuticalcompanies align with highly targeted healthcare media platforms, content creators, or events to reach specific audiences—be they physicians, specialists, patients, or caregivers. One misstep can invite FDA warning letters or damage brand credibility.
However, the Food and Drug Administration (FDA) has approved a generic mixture of ipratropium and albuterol —Combivent Respimat’s active ingredients—for use by COPD patients. Generic drugs are often more affordable than their brand-name references, but unfortunately, there are no current generics for Combivent Respimat.
Koblitz Integral to the careful balance Congress struck when passing the Hatch-Waxman Amendments, the patent term extension (PTE) is intended to restore patent life that was consumed during regulatory review of an FDA-regulated product. FDA has already been there , of course, with respect to 180-day exclusivity.)
Disease awareness campaigns can also reach specific patient groups based on demographics and interests, helping pharmaceuticalcompanies create more personalized outreach. Can pharmaceuticalcompanies run direct-to-consumer ads on social media? Yes, but regulations vary by region. In the U.S.,
Every message must be accurate, balanced, and FDA-compliant. Unlike consumer brands, pharmaceuticalcompanies must pass content through multiple layers of medical, legal, and regulatory review. Regulatory Complexity Pharma marketers operate in one of the most heavily regulated industries. This often delays time to market.
For starters, trust in pharmaceuticalcompanies remains fragile. If a pharma brand uses a video ad on social media, it must ensure that risk information is equally prominent, or else face FDA scrutiny. Even large pharmaceuticalcompanies sometimes struggle to extract value from their tech stack.
According to McKinsey, 70% of pharmaceuticalcompanies now use AI in marketing workflows. Is AI in pharma marketing FDA-regulated? While AI itself isnt regulated, any content or interaction that includes product claims must follow FDA promotional guidelines. Which departments should be involved in AI implementation?
With the growing adoption of AI-powered tools, pharmaceuticalcompanies can now deliver more targeted, timely, and meaningful interactions to both healthcare professionals (HCPs) and patients. Can AI improve ROI in pharmaceutical campaigns? Is AI-generated content compliant with FDA regulations?
Introduction Pharmaceuticalcompanies are investing heavily in digital advertising , and PPC campaign optimization is key to maximizing ROI while staying compliant. Optimize landing pages to ensure message consistency and compliance with FDA regulations. For more PPC advertising solutions, explore eHealthcare Solutions.
Mounjaro (tirzepatide) is a brand-name prescription medication that is approved by the Food and Drug Administration (FDA) to improve blood sugar levels in people with Type 2 diabetes. The FDA recently approved generic versions of two other GLP-1s , Victoza (liraglutide) and Byetta (exenatide). Is there a generic for Mounjaro?
1 The FDA recommended that the US Drug Enforcement Administration (DEA) move medical marijuana from Schedule I to Schedule III. 2 This determination was based on the FDA’s evaluation of abuse potential, dependency, and accepted medical use for marijuana. Medical marijuana is defined as cannabis that contains no more than 0.3%
This is progressing through a phase 3 trial and includes comparator arms with standard-of-care treatments like daratumumab, bortezomib (Velcade; Millennium/Takeda and Janssen PharmaceuticalCompanies), and lenalidomide. 2 We’re still trying to figure out where these new treatments best fit.
The FDA mandates randomized clinical trials to assess long-term opioid use benefits and risks, ensuring timely and efficient completion. SHOW MORE FDA mandates new opioid labeling to highlight long-term risks, aiming to combat addiction and improve patient safety in pain management. FDA Commissioner Marty Makary, M.D.,
Brand Authority: By appearing at the top of search engine results, pharmaceuticalcompanies increase brand credibility among HCPs. Use a mix of: Branded Keywords: Drug names, pharmaceuticalcompanies, or treatment-specific terms. Competitive Keywords: Terms related to rival brands, helping capture market share.
Marketers must balance innovation with compliance to avoid FDA warnings or public mistrust. All campaign assets—whether for branded drugs like Eliquis or unbranded disease awareness—must comply with FDA regulations on fair balance, risk disclosure, and promotional claims. All pharmaceutical advertising is subject to FDA guidelines.
Brand-name vs. generic antibiotics Brand-name antibiotics are made by the pharmaceuticalcompanies that originally developed them. Both types of drugs are approved by the Food and Drug Administration (FDA) to treat certain conditions, like bacterial infections. tablet, capsule, or liquid) Route of administration (e.g.,
The Orange Book is the reference, and it allows the FDA to declare something [to be] therapeutically equivalent. The FDA Approval Process Within the FDA approval process, the 505(b)(1) new drug application (NDA) submission pathway is the pathway by which new drugs are able to seek approval.
An ad exchange is a real-time digital marketplace where advertisers (such as pharmaceuticalcompanies) buy and sell ad inventory across multiple websites and platforms through automated bidding. Yes, as long as your creative meets FDA guidelines and includes risk disclosures and fair balance.
Pharmaceuticalcompanies have responded with growing investment in the research and development of novel eye treatments and drug delivery systems designed to address key challenges in ocular therapy. Challener News Article Hydrogels, drug-eluting contact lenses, and other implant technologies show real promise. PLoS ONE 2011 6, e24513.
8 Pharmacists also play a crucial role in access to medications for patients who might need payment assistance with assistance programs, communicating with insurers, or working with pharmaceuticalcompanies to ensure that treatment is not delayed due to these barriers.
NP Thyroid is derived from a natural source, the thyroid glands of pigs, and it is made by the pharmaceuticalcompany Acella. In fact, NP Thyroid has not been through the FDA approval process, which is likely why many health insurance plans exclude it or require additional steps for coverage. Is NP Thyroid covered by insurance?
This is what the FDA requires for botanical drug approval: evidence, consistency, and repeatability. Analytical chemistry, biomanufacturing, and stringent quality controls enable the mapping, measurement, and standardization of the full chemical fingerprint of a plant-based therapeutic.
Additionally, regulatory bodies like the FDA are encouraging patient-focused communications, further legitimizing this trend. The Inflation Reduction Act and new drug pricing regulations are pushing pharmaceuticalcompanies to justify value more transparently.
It is the active ingredient in the brand-name , FDA-approved drugs Ozempic , Wegovy , and Rybelsus. Novo Nordisk is the only pharmaceuticalcompany that makes FDA-approved medications containing semaglutide. Like Ozempic , Rybelsus is sometimes prescribed off-label for weight loss.
Image Credit: Adobe Stock Images/涛 王 Key Takeaways FDA Label Update: Novartis’ Leqvio is now approved for first-line monotherapy use to lower low-density lipoprotein cholesterol (LDL-C) in adults with hypercholesterolemia. 1 How Will the FDA’s New Label Update Impact Leqvio’s Role in Cholesterol Management? link] FDA Approves Leqvio.
Facility construction takes years, and new suppliers must meet FDA standards before production can even begin. Impact on Pharma Marketing and Innovation Budgets If 200% tariffs become the norm, pharmaceuticalcompanies will face brutal budget reallocations. Could pharma companies relocate their supply chains domestically?
Expedition chairman and CEO Yi Larson stated: “We are pleased to be working with Fosun Pharma, one of the leading pharmaceuticalcompanies in China. XH-S004 is an exciting compound that targets neutrophilic inflammation, an important underlying driver of a number of chronic respiratory diseases. “We
Waite further emphasizes the need for pharmaceuticalcompanies to quickly build internal capabilities in customs compliance, including tariff classification, country of origin documentation, and accurate customs valuation. I haven't seen it yet, but there's certainly talk that, you know, that that could be the outcome here.
July 31st 2025 Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research Miranda Schmalfuhs LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Snow & Dara Katcher Levy In a recent letter to FDA Commissioner Dr. Martin Makary, U.S. stating that he would advise President Trump to ban pharmaceutical advertising on TV. Durbins letter addresses FDAs capacity to oversee the increasing volume of DTC advertisements, particularly on platforms like social media. Kennedy Jr.,
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content